===================================================================
Report ID.....................3,doc3
Patient ID....................pt123456789
Patient Name..................PatientX
Principal Date................20101202
Record Type...................NOTE
===================================================================
[Report de-identified (Limited dataset compliant) by De-ID v.6.24.5.1]


DIAGNOSIS:  Stage IIA (T1 N1 M0) infiltrating ductal carcinoma, left breast, 
triple negative.

Therapy completed 9 cycles of weekly Abraxane.

REASON FOR VISIT:  Assess response to neoadjuvant chemotherapy.

Patient92 returns to the office today for ongoing management of biopsy-proven left breast cancer with axillary lymph node metastasis.
Her initial office visit was on September 30, 2010.
Her clinical breast examination at that time was significant for a 2 cm palpable mass in the upper outer aspect of the left breast extending from 12:30 o'clock.
She also had multiple abnormally enlarged left axillary lymph nodes.

She has now completed 9 of a planned 12 cycles of weekly Abraxane.
She has tolerated her chemotherapy overall without significant sequela.
She denies any hospitalizations.

Her past medical history, surgical history, medications, and allergies were reviewed as noted in the electronic medical record.

IMPRESSION:  Partial response to neoadjuvant chemotherapy for a locally advanced, triple negative, left breast cancer.